British guidelines

The British HIV Association

The British HIV Association (BHIVA) guidelines on the use of antiretroviral therapy were developed by a panel of doctors and community advocates and first published in The Lancet in April 1997.

The guidelines discussed in this section were released in 2008 and are a joint project of the British Association for Sexual Health and HIV (BASHH), BHIVA, and the British Infection Society (BIS) in consultation with other professional, community, and governmental organisations.1 They update the last version of the guidelines, published in 2006.

Using an evidence-based medicine approach, BHIVA guidelines for the treatment of HIV-infected adults with antiretroviral therapy offers broad principles based on consensual opinion to aid, but not dictate, clinical practice. In the formulation of these guidelines, experts in the HIV medicine field have assessed clinical trial results, peer-reviewed publications, and conference abstracts with possible implications for clinical practice.

Other BHIVA HIV treatment guidelines that are available, awaiting publication, or under review cover the topics of adherence, HIV/hepatitis co-infection, HIV/TB co-infection, HIV-associated malignancies, immunisation, pregnancy, renal and liver transplantation, HIV-2 infection, and sexual and reproductive health management. In 2007, BHIVA along with BASHH, BIS, and the Royal College of Physicians (RCP), published Standards for HIV Clinical Care (available for download on the BHIVA website www.bhiva.org).

References

  1. Gazzard BG, BHIVA Treatment Guidelines Writing Group British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med 9(8): 563-608. Available online at www.bhiva.org, 2008
This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.